Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears testimony on bill to restrict puberty blockers for minors
Summary
The Public Health and Community Health Committee held a hearing on Senate Bill 30, which would prohibit prescription of puberty-blocking medication for gender dysphoria in minors; medical witnesses and lawmakers discussed clinical exceptions, potential effects on standard care and whether bill language needs clarification. No vote was taken.
The Public Health and Community Health Committee on an announced date heard testimony on Senate Bill 30, a proposal by Senator Watson to prohibit prescription or administration of puberty-blocking medications for gender dysphoria in minors.
The bill’s sponsor, Senator Watson, described SB 30 as “a continuation of SB 140” and said the measure is intended to “clean[] up” earlier law by barring puberty blockers for gender dysphoria while preserving their use for other medical conditions the bill explicitly exempts. Watson told the committee that countries including Norway, Denmark, Finland and the United Kingdom have moved to restrict the drugs for minors and listed possible adverse effects Senate staff cited from clinical references, including decreased bone density and increased suicidality.
Dr. Michelle…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
